Life Sciences Times

Nuclera, leadXpro Partner to Speed Structure-Based Drug Design for Membrane Proteins

FDA Accepts Tirabrutinib NDA for Relapsed or Refractory PCNSL, Sets December 2026 Decision Date

BostonGene, Daiichi Sankyo Partner to Use AI Analytics to Advance Cancer Drug Development

Artis BioSolutions Names Dr. Kate Broderick as Chief Scientific Innovation Officer

UNC Health Selects Mevion for Compact Proton Therapy System Expansion

Terray Unveils New EMMI Predict Model Claiming Major Gains in Accuracy and Speed for Drug Discovery

Phase III KALOS and LOGOS Trial Results for BREZTRI in Uncontrolled Asthma Published in The Lancet Respiratory Medicine

MEDIPOST Submits IND Amendment to FDA to Support Phase III Knee Osteoarthritis Trial

Wolters Kluwer Outlines Medi-Span Expert AI Initiative to Power Medication Intelligence for Digital Health

SURGE Therapeutics Completes Phase 1 Dosing of Intraoperative Immunotherapy and Prepares for Registrational Trial